Brind.

Analyst Comparison Highlights Differences Between Veeva Systems and Definitive Healthcare

1 report, 1 independent Updated Tue 00:00
AI-generated briefing. Brind wrote this from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

A comparison was made between Veeva Systems and Definitive Healthcare in the healthcare sector. Reports indicate that Veeva Systems has higher revenue and earnings than Definitive Healthcare. However, research analysts suggest Definitive Healthcare is more favorable due to its higher probable upside, with a consensus target price of $1.47 compared to Veeva Systems' $314.50.

From dailypolitical.com

Why it matters

Some supportBrind's analysis of the reports

The comparison highlights differences in market perception and risk profiles between the two companies. Definitive Healthcare has a beta of 1.4, suggesting its share price is 40% more volatile than the S&P 500. Conversely, Veeva Systems has a beta of 0.89, suggesting its share price is 11% less volatile than the S&P 500.

From dailypolitical.com

Who's involved

  • Veeva SystemsCloud computing company being compared in the healthcare sector
  • Peter GassnerCEO and founder of Veeva Systems
  • Matt FarrellPresident at Veeva Systems
  • BiogenBiotechnology company that utilizes Veeva's Vault CRM platform
  • SECRegulatory body that mandates disclosure and reporting obligations for Veeva Systems

Who could feel it

Possible knock-on effects

These are possibilities Brind reasoned out, not predictions, and not advice. Most are not stated in any report.

  • Veeva SystemsSpeculative

    Veeva Systems might see changes in its market price due to the unfavorable analyst comparison against Definitive Healthcare.

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped